HomeNewsRespiratory

  • KALYDECO in Cystic Fibrosis receives positive CHMP opinion by EMA

    • October 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Positive results from new triple combinations in Cystic Fibrosis, displayed by Vertex

    • October 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Dupixent® (Dupilumab) approved by FDA for Asthma indication

    • October 21, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Synspira’s drug receives FDA Orphan Designation for Cystic Fibrosis treatment

    • October 16, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Samumed And United Therapeutics enter Agreement For Ph I IPF Drug

    • September 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roivant acquires therapy to treat Chronic Cough in IPF patients

    • September 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Esbriet dose modifications do not alter treatment effect in IPF, study finds

    • August 29, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Preclinical Study Results presented for IPF drug BBT-877, by Bridge Biotherapeutics

    • August 23, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA Approves ORKAMBI in Cystic Fibrosis for Children Ages 2-5 Years

    • August 13, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Boehringer Ingelheim to Develop novel Gene Therapy for Cystic Fibrosis

    • August 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more